Prostate Cancer - Results from #100

ASCL1 Activates Neuronal Stem Cell-like Lineage Programming Through Remodeling of the Chromatin Landscape in Prostate Cancer April 28, 2022

Cost-effectiveness of enzalutamide versus apalutamide versus androgen deprivation therapy alone for the treatment of metastatic castration-sensitive prostate cancer in Canada. April 28, 2022

A Prospective Study of High Dose-Rate Brachytherapy or Stereotactic Body Radiotherapy of Intra-Prostatic Recurrence: Toxicity and Long Term Clinical Outcome. April 28, 2022

Prostate Cancer with Peritoneal Carcinomatosis: A robotic-assisted radical prostatectomy-based Case Series. April 28, 2022

The cost impact of disease progression to metastatic castration-sensitive prostate cancer. April 28, 2022

High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium. April 28, 2022

Causes of Death Among Patients With Metastatic Prostate Cancer in the US From 2000 to 2016. April 28, 2022

Intensification of Systemic Therapy in Addition to Definitive Local Treatment in Nonmetastatic Unfavourable Prostate Cancer: A Systematic Review and Meta-analysis. April 27, 2022

The added influence of genomics and post-MRI confirmatory biopsy results to MRI results alone on medical decision making for men with favorable risk prostate cancer being considered for active surveillance. April 27, 2022

Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance. April 27, 2022

Pseudoprospective Paraclinical Interaction of Radiology Residents With a Deep Learning System for Prostate Cancer Detection: Experience, Performance, and Identification of the Need for Intermittent Recalibration. April 27, 2022

GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol). April 27, 2022

Ductal Prostate Cancers Demonstrate Poor Outcomes with Conventional Therapies. April 27, 2022

Concordance between Preoperative mpMRI and Pathological Stage and Its Influence on Nerve-Sparing Surgery in Patients with High-Risk Prostate Cancer. April 26, 2022

Changes in prostate cancer incidence, mortality and survival in relation to prostate specific antigen testing in New South Wales, Australia. April 26, 2022

Artificial intelligence supporting cancer patients across Europe-The ASCAPE project. April 26, 2022

Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216). April 26, 2022

Aggressive Prostate Cancer at Presentation Following Solid Organ Transplantation. April 26, 2022

Full functional-length urethral sphincter- and neurovascular bundle preservation improves long-term continence rates after robotic-assisted radical prostatectomy. April 25, 2022

Interferon-γ increases sensitivity to chemotherapy and provides immunotherapy targets in models of metastatic castration-resistant prostate cancer. April 25, 2022

Page 6 of 1224

email news signup